Accueil > BIGG > Résultat de la recherche

    Résultats: 4

    Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC

    Sterling, Timothy R; Njie, Gibril; Zenner, Dominik; Cohn, David L; Reves, Randall; Ahmed, Amina; Menzies, Dick; Horsburgh, C. Robert; Crane, Charles M; Burgos, Marcos; LoBue, Philip; Winston, Carla A; Belknap, Robert.
    MMWR recomm. rep; 69 (1), 2020
    Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221–47). S...
    Tuberculose latente/traitement médicamenteux, Résistance bactérienne aux médicaments, Mycobacterium tuberculosis/effets des médicaments et des substances chimiques, États-Unis, Antituberculeux/usage thérapeutique, Tuberculose latente/diagnostic
    Texte intégral

    Latent TB infection: updated and consolidated guidelines for programmatic management

    World Health Organization.
    Background The programmatic management of latent tuberculosis infection (LTBI) in populations most at risk of developing TB remains a critical activity to disrupt Mycobacterium tuberculosis transmission, as identified in the End TB Strategy. LTBI is defined as a state of persistent immune response to sti...
    Tuberculose latente/traitement médicamenteux, Tuberculose latente/prévention et contrôle, Tuberculose latente/diagnostic, Traçage des contacts, Appréciation des risques, Algorithmes, Infections à VIH, Antituberculeux/administration et posologie
    Texte intégral

    Guidelines on the management of latent tuberculosis infection

    World Health Organization.
    Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active TB. A direct measurement tool for M. tuberculosis infection in humans is currently unavailable. The vast majority...
    Antituberculeux/usage thérapeutique, Mycobacterium tuberculosis/immunologie, Tests immunologiques, Tuberculose latente/diagnostic, Tuberculose latente/traitement médicamenteux, Survivants à long terme d'une infection à VIH
    Texte intégral

    Guidelines on the Management of Latent Tuberculosis Infection

    World Health Organization.
    The overall objective of the guidelines is to provide public health approach guidance on evidencebased practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. The guidelines are expected to provide the basis and rationale for the developmen...
    Antituberculeux/administration et posologie, Tuberculose latente/traitement médicamenteux, Tuberculose latente/prévention et contrôle, Populations vulnérables, Résultat thérapeutique, Adhésion au traitement médicamenteux, Rifampicine/administration et posologie, Isoniazide/administration et posologie, Association de médicaments, Tuberculose latente/diagnostic
    Texte intégral (lien principal)     Texte intégral (lien alternatif)     Texte intégral (lien alternatif)